Clinical radioimmunotherapy—the role of radiobiology

JP Pouget, I Navarro-Teulon, M Bardiès… - Nature reviews Clinical …, 2011 - nature.com
Conventional external-beam radiation therapy is dedicated to the treatment of localized
disease, whereas radioimmunotherapy represents an innovative tool for the treatment of …

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

L Chang, PH Graham, J Ni, J Hao, J Bucci… - Critical reviews in …, 2015 - Elsevier
Abstract The phosphatidylinositol-3-kinase/Akt and the mammalian target of rapamycin
(PI3K/Akt/mTOR) pathway is one of the most frequently activated signaling pathways in …

Increased apoptotic potential and dose‐enhancing effect of gold nanoparticles in combination with single‐dose clinical electron beams on tumor‐bearing mice

MY Chang, AL Shiau, YH Chen, CJ Chang… - Cancer …, 2008 - Wiley Online Library
High atomic number material, such as gold, may be used in conjunction with radiation to
provide dose enhancement in tumors. In the current study, we investigated the dose …

Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy

A Abdollahi, J Folkman - Drug Resistance Updates, 2010 - Elsevier
Within three decades, anti-angiogenic therapy has rapidly evolved into an integral
component of current standard anti-cancer treatment. Anti-angiogenic therapy has fulfilled a …

Targeting apoptosis pathways by Celecoxib in cancer

V Jendrossek - Cancer letters, 2013 - Elsevier
Celecoxib is a paradigmatic selective inhibitor of cyclooxygenase-2 (COX-2). This anti-
inflammatory drug has potent anti-tumor activity in a wide variety of human epithelial tumor …

[HTML][HTML] Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice

S Ganai, RB Arenas, NS Forbes - British journal of cancer, 2009 - nature.com
Background: An effective cancer therapeutic must selectively target tumours with minimal
systemic toxicity. Expression of a cytotoxic protein using Salmonella typhimurium would …

Anticancer mechanisms and clinical application of alkylphospholipids

WJ van Blitterswijk, M Verheij - … et Biophysica Acta (BBA)-Molecular and …, 2013 - Elsevier
Synthetic alkylphospholipids (ALPs), such as edelfosine, miltefosine, perifosine,
erucylphosphocholine and erufosine, represent a relatively new class of structurally related …

Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects

WJ van Blitterswijk, M Verheij - Current pharmaceutical design, 2008 - ingentaconnect.com
Synthetic anticancer alkylphospholipids (APLs), such as edelfosine, miltefosine and
perifosine, are a group of structurally related lipids that act on cellular membranes rather …

[HTML][HTML] Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation

CP Yu, JY Ho, YT Huang, TL Cha, GH Sun, DS Yu… - PloS one, 2013 - journals.plos.org
Renal cell carcinoma (RCC) originates in the lining of the proximal convoluted tubule and
accounts for approximately 3% of adult malignancies. The RCC incidence rate increases …

TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis

CA Dumitru, E Gulbins - Oncogene, 2006 - nature.com
We have previously shown that activation of the acid sphingomyelinase (ASM), the release
of ceramide and the formation of ceramide-enriched membrane domains are central for the …